2004-06-30

Sandoz to strengthen Danish market position and Nordic operations with acquisition of Astra Zeneca’s generics subsidiary in Denmark

Acquisition of Durascan makes Sandoz number two player in local generics market Vienna, June 30, 2004 Sandoz today announced the acquisition of Durascan, the generic subsidiary of Astra Zeneca in Denmark, in a transaction aimed at claiming the number two position in the Danish generics market and establishing a new operational hub in the Nordic region. Financial details of the transaction were not disclosed. Press Release

Tillbaka till nyheter